Cardiovascular GLP-1 Webinar
The Impact of GLP-1s on Cardiovascular Clinical Development
Join this timely webinar presentation to gain an understanding of the potential application of GLP-1 RAs in the treatment of cardiovascular indications, how the landscape for cardiovascular clinical research is changing, and what this means for the future of cardiovascular clinical trials.
Speakers:
- Adrienne Richards, M.D., medical science and strategy lead, cardiovascular, PPD clinical research business, Thermo Fisher Scientific
- Rose Blackburne, M.D., therapeutic area head, medical science and strategy, PPD clinical research business, Thermo Fisher Scientific
- Marlena Erikson, senior director, project oversight, PPD clinical research business, Thermo Fisher Scientific
- (Moderator) Paul Collins, executive director and cardiovascular pillar head, PPD clinical research business, Thermo Fisher Scientific
Complete the form to watch the webinar on demand.
To learn about the medical and operational challenges associated with the clinical development of novel glucagon-like peptide-1 (GLP-1) receptor agonists specific to diabetes, obesity and metabolic clinical trials, watch another on-demand webinar.